You are adding an alert for:
Retro-IDEAL study - results from real-world practice show that after substantial amounts of prior treatment with anti-VEGF and other therapies a single ILUVIEN (fluocinolone acetonide; FAc) implant leads to sustained improvements lasting up to 36 months.
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: